Looking ahead in the clinical lab: What’s next after COVID-19?

Since the onset of the SARS-CoV-2 pandemic, many clinical laboratories acquired new molecular diagnostic platforms to reduce send out costs and expedite test results. While COVID-19 testing is still a priority, many laboratories are faced with the question: what next? How can we get the most out of our new platforms while juggling supply chain issues and limited staffing?

In this SelectScience webinar, Dr. Jessica VanAllen, Lead Technical Support Specialist at ZeptoMetrix, will provide insight into the current infectious disease testing landscape, and highlight a path forward for clinical laboratories that ensures accurate infectious disease monitoring and result generation.

Key learning objectives

• How labs are expanding beyond COVID-19 testing with limited resources
• How to get the most out of your laboratory quality controls
• How ZeptoMetrix can help laboratories expand their testing menus and move forward after COVID-19

Who should attend?

• Laboratory Managers
• Laboratory Directors

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.